Thursday, June 11

Browsing: RCHOP

Treatments

Tafasitamab Combo Prolongs Progression vs R-CHOP Alone in BCL Groups

By NewsCancerMay 30, 20260

The addition of tafasitamab (Monjuvi) and lenalidomide (Revlimid) to a regimen consisting of rituximab (Rituxan), cyclophosphamide, doxorubicin, vincristine, and prednisone…

Survivors

Moving Beyond R-CHOP: The Future of Upfront Precision Oncology in Lymphoma

By NewsCancerMay 15, 20260

Precision oncology in lymphoma is evolving beyond reactive monitoring toward a proactive, personalized paradigm. In an interview with CancerNetwork®, Hua-Jay…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Browsing: RCHOP

Tafasitamab Combo Prolongs Progression vs R-CHOP Alone in BCL Groups

Moving Beyond R-CHOP: The Future of Upfront Precision Oncology in Lymphoma

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Latest Post

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Subscribe to Updates

What's Hot

Browsing: RCHOP